Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Actelion Pharmaceuticals Ltd" found in our extensive corporate database of over 50,000 company records.
Actelion aims to discover or in-license and develop a steady stream of new products as revenue sources, based on first-in class small molecule compounds. In doing so, Actelion is focussing on innovative treatments for high-unmet medical needs, where Actelion’s new drugs can bring therapeutic advantage to patients and economic benefit for the community at large. Pursue comprehensive life cycle an...
Actelion Ltd is a biopharmaceutical company with its corporate headquarters in Allschwil/Basel, Switzerland. Actelion's first drug Tracleer® (bosentan), an orally available dual endothelin receptor antagonist, has been approved as a therapy for pulmonary arterial hypertension. Actelion markets Tracleer® through its own subsidiaries in key markets worldwide, including the United States (based in ...
Actelion Ltd, a biopharmaceutical company headquartered in Allschwil / Basel, Switzerland, is a leading player in innovative science related to the endothelium - the single layer of cells separating every blood vessel from the blood stream.Actelion focuses on the discovery, development and marketing of innovative drugs for significant unmet medical needs.
Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as well as developing technologies to solubilise insoluble pharmaceuticals.
Excaliard Pharmaceuticals, Inc., is a venture capital-funded biotechnology company founded in 2007 focused on the development and commercialization of novel and innovative drugs for the amelioration of skin scarring and other fibrotic disorders. EXC 001 was co-discovered by Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) and Excaliard, and licensed to Excaliard Pharmaceuticals.
Founded in 2007 and located in Milford, Pennsylvania, Serenity Pharmaceuticals is focused on developing products that address urinary conditions that impact the health and well-being of millions of people. Serenity Pharmaceuticals is working to develop patented pharmaceuticals with unique delivery mechanisms and formulations, to provide safe and effective ...
AVANIR Pharmaceuticals, formerly LIDAK Pharmaceuticals, is a development stage company organized to discover, develop, and market novel therapeutic products to treat human diseases.
Dr. McLaughlin is currently the professor of medicine and director of the Pulmonary Hypertension Program in the Division of Cardiovascular Medicine at the University of Michigan in Ann Arbor, Michigan. Dr. McLaughlin received her bachelor's degree in biomedical engineering at Northwestern University, Technologic Institute, Evanston, Illinois, and her doctor of medicine from Northwestern Universit...
Future Pharmaceuticals magazine draws connections between industry leaders and pharmaceutical companies. Future Pharmaceuticals recommends next generation and groundbreaking strategies to ensure success across the enterprise.
KalGene Pharmaceuticals Inc. is a biotech company, currently residing at JLABS @ Toronto, Ontario. The mission of KalGene Pharmaceuticals is to develop precision medicine therapeutics for effective treatment of Alzheimerâs disease.
Mountain View Pharmaceuticals is dedicated to the development and application of inovative chemical technology for enhancing the utility of protein-based pharmaceuticals.
Gemini Pharmaceuticals Inc. is a global manufacturer of specialty pharmaceuticals, Over the Counter (OTC) pharmaceuticals, and dietary and nutritional supplements. With over 30 years of experience, Gemini has grown to be a world class manufacturer of solid dosage product with production exceeding 18 billion tablets / capsules per year. The quality of the o...
Sucampo Pharmaceuticals, Inc. is a global pharmaceutical company focused on innovative research, discovery, development and commercialization of proprietary drugs based on prostones. The therapeutic potential of prostones, which occur naturally in the human body as a result of enzymatic (15-PGDH) transformation of certain fatty acids, was first identified ...
Elevation Pharmaceuticals is a biopharmaceutical company focused on developing new inhaled therapies for patients with respiratory disease. The Company was founded in 2008 by Cam Garner, formerly Chairman and CEO of Dura Pharmaceuticals, Bill Gerhart, formerly President and CEO of Mpex Pharmaceuticals, and Ahmet Tutuncu, formerly VP of Medical Affairs at Verus Pharmaceuticals. The Company's init...
The purpose of the Center for Research on Pharmaceuticals is to establish an internationally known, multidisciplinary network for research and development of pharmaceuticals and medical device, from which the industry can buy services and within which inventions at the university will obtain a good environment for future commersialization.
Sigma-Tau Pharmaceuticals, Inc. is a U.S. based, wholly owned subsidiary of the sigma-tau Group, and is dedicated solely to the global development and commercialization of medicines for patients with rare diseases. Sigma-Tau Pharmaceuticals, Inc. is based in Gaithersburg, Maryland.
Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing KRYSTEXXA(TM) (pegloticase) for the treatment of chronic gout in patients refractory to conventional therapy. Savient has exclusively licensed worldwide rights to the technology related to KRYSTEXXA, formerly referred to as Puricase®, from Duke University and Mountain View Pharmaceuticals, Inc. Savient al...
Pilot Pharmaceuticals develops novel products to treat CNS disorders with unmet medical need and substantial market size. The Company takes candidate drugs from an early discovery stage into clinical development.Pilot Pharmaceuticals will license its products to pharmaceutical companies, allowing them to complete the clinical development, gain regulatory approval and market the product.Pilot Pharm...
Aries Pharmaceuticals, Inc. (Aries) is a specialty pharmaceutical company commercializing best-in-class gastroenterology products for the United States market with a focus on products utilized in endoscopy and for the treatment of specificÂ gastrointestinal diseases. The companyâs initial portfolio of four products, three of which are still in devel...
New Zealand Pharmaceuticals (NZP) is leading the way for the biotechnology industry development in New Zealand. It manufactures and exports pharmaceutical intermediates and diagnostics products for the world?s leading pharmaceuticals and biotechnology companies. It also produces a range of dietary supplements
Hawthorn Pharmaceuticals began in 1998 with two products and four sales professionals. Today, Hawthorn has 28 uniquely formulated products on the market with several more slated for introduction this year. Hawthorn currently has over 100 sales professionals marketing products throughout the Southeastern United States. Hawthorn Pharmaceuticals' corporate headquarters are located in Madison, Mississ...
Ritter Pharmaceuticals is dedicated to helping individuals live a healthier and happier life style through improved digestion. Ritter Pharmaceuticals focuses on the discovery, development and commercialization of innovative therapeutic treatments for gastrointestinal diseases and conditions. One of these products is Lactagen®, a dietary supplement developed to help reduce symptoms of lactose in...
Changzhou Jiaerke Pharmaceuticals Group Corp.,Ltd. Is a professional pharmaceuticals company, which has more than 20 years of experiences in producing steroid hormone products and other organic chemical products. Jiaerke Pharma. Has occupied a certain market share and enjoyed higher reputation.
Hoffmann-La Roche Inc. (Roche), based in Nutley, N.J., is the U.S. pharmaceuticals headquarters of the Roche Group, one of the world's leading research-oriented healthcare groups with core businesses in pharmaceuticals and diagnostics. For more than 100 years in the U.S., Roche has been committed to developing innovative products and services that address prevention, diagnosis and treatment of dis...
IDEC Pharmaceuticals Corporation is a biopharmaceutical company engaged primarily in the research, developmentand commercialization of targeted therapies for the treatment of cancer and autoimmune and inflammatory diseases. IDEC Pharmaceuticals first commercial product, Rituxan, and their most advanced product candidate, IDEC-Y2B8, are for use in the treatment of certain B-cell NHLs. IDEC Pharmace...